Kera Capital Partners, Inc. Jazz Pharmaceuticals PLC Transaction History
Kera Capital Partners, Inc.
- $631 Million
- Q3 2025
Shares
2 transactions
Others Institutions Holding JAZZ
# of Institutions
573Shares Held
61.8MCall Options Held
856KPut Options Held
178K-
Black Rock Inc. New York, NY6.15MShares$867 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA5.91MShares$833 Million0.01% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.84MShares$400 Million0.08% of portfolio
-
Capital World Investors Los Angeles, CA2.55MShares$360 Million0.05% of portfolio
-
Lsv Asset Management Chicago, IL2.51MShares$354 Million0.73% of portfolio
About Jazz Pharmaceuticals plc
- Ticker JAZZ
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 62,680,700
- Market Cap $8.84B
- Description
- Jazz Pharmaceuticals plc, a biopharmaceutical company, identifies, develops, and commercializes pharmaceutical products for various unmet medical needs in the United States, Europe, and internationally. The company has a portfolio of products and product candidates with a focus in the areas of neuroscience, including sleep medicine and movement ...